-
18 Whole Exome Sequencing for Radiation Induced-Meningiomas
Study
EGAS00001002317
-
Breast cancer women lack normal lifelong immune response after full-term pregnancies
Study
EGAS00001002616
-
DSRCT RNA genomic sequencing
Study
EGAS00001002770
-
Accurate detection and classification of pediatric sarcomas based on cell-free DNA fragmentation patterns
Study
EGAS00001005127
-
Genetic diversity and continuity of the population of the UAE
Study
EGAS00001004362
-
Matching of actionable mutations with therapies in cancer patients: comparison of three commercial decision support platforms
Study
EGAS00001004383
-
Combining a Universal Telomerase Based Cancer Vaccine with Ipilimumab in Patients with Metastatic Melanoma - Five-year Follow up of a Phase I/IIa Trial
Study
EGAS00001005253
-
Post_Mortem_Tissue_COVID19_spatial
Study
EGAS00001004441
-
Tumor-specific expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer
Study
EGAS00001004001
-
An analysis of humoral and cellular immune responses following COVID-19 vaccination.
Study
EGAS00001005380
-
Analysis of RAD51C promoter methylation using targeted bisulfite sequencing (amplicon sequencing) in ovarian cancer pre-clinical models and patient samples.
Study
EGAS00001005395
-
IMCISION DNAseq
Study
EGAS00001005466
-
Characterization of DLBCL with a PMBL gene expression signature
Study
EGAS00001005057
-
Whole genome sequencing of a breast cancer cohort with known functional homologous recombination status
Study
EGAS00001005572
-
Genetics and therapeutic responses to TIL therapy of pancreatic cancer PDX models
Study
EGAS00001005596
-
Proteom characterization in primary colorectal cancer and corresponding liver metastasis
Study
EGAS00001005641
-
Genetic Risk for Subsequent Neoplasms among Long-term Survivors of Childhood Cancer in the St. Jude Lifetime Cohort
Study
EGAS00001002499
-
Functional Mapping of AKT Signaling and Biomarkers of Response From the FAIRLANE Trial of Neoadjuvant Ipatasertib Plus Paclitaxel for Triple-Negative Breast Cancer
Study
EGAS00001005892
-
Genomic landscape of oral cancers (Illumina WGS)
Study
EGAS00001003228
-
Monocyte and macrophage lipid accumulation results in downregulated type-I interferon responses
Study
EGAS00001005955
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Breast cohort
Study
EGAS00001004446
-
Profiling the unique protective properties of intracranial arterial endothelial cells
Study
EGAS00001004479
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM67 WES
Study
EGAS00001004555
-
Germline variants in patients with rare cancers and their implications for precision cancer medicine: experiences from the Multicenter MASTER Trial by the German Cancer Consortium (HIPO_021)
Study
EGAS00001005537
-
Stromal-induced epithelial-mesenchymal transition induces drug resistance in acute lymphoblastic leukemia
Study
EGAS00001006120
-
Exploration of coding and non-coding variants in cancer using GenomePaint.
Study
EGAS00001004669
-
Molecular and clinical diversity in primary central nervous system lymphoma: a LOC Network study
Study
EGAS00001006191
-
Combined MEK and BCL-2/XL inhibition is effective in high-grade serous ovarian cancer patient-derived xenograft models and BIM levels are predictive of responsiveness
Study
EGAS00001003427
-
Analysis of error profiles in deep next-generation sequencing data
Study
EGAS00001003444
-
Identification of the dismal subtype of B-ALL with dysregulation of CDX2 and UBTF
Study
EGAS00001005863
-
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
Study
EGAS00001005876
-
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma (H033)
Study
EGAS00001003481
-
Genetic immune escape landscape in primary and metastatic cancer
Study
EGAS00001006123
-
Combination of CDK4/6 with BET-bromodomain and PI3K/mTOR inhibitors in medulloblastoma in vitro and in vivo
Study
EGAS00001006286